What is CorMedix's contract revenue — total revenue?

CorMedix (CRMD) reported contract revenue — total revenue of $5.51M in Q1 2026.

What does contract revenue — total revenue mean?

This metric represents the total revenue generated specifically from contractual arrangements, such as licensing agreements, research collaborations, or service-based partnerships. It reflects the company's ability to monetize its intellectual property or specialized capabilities through external business relationships rather than direct product sales. Monitoring this stream helps investors assess the diversification of income sources and the strategic value of the company's partnership ecosystem.

CorMedix (CRMD) Contract revenue — Total Revenue

Screener

Other product segments

DefenCath

$97.51M+150%

Melinta Portfolio

$24.41M—

Similar metrics at other companies

BIIBContract manufacturing revenue — Total Revenue

$232.4M+3.3%

IBRXOther revenues — Total Revenue

$39K+388%

MARNet fee revenues — Total Revenue

$1.4B+12.1%

BIIBMS Product Revenues — Total Revenue

$963.3M-13.0%

PTH

PTHSNet product revenues — Total Revenue

$10.67M—

CTRIBid contracts — Total Revenue

$189.11M+44.5%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$583.68M-22.4%

P/E3.2×—

P/S1.5×-4.7×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CorMedix’s 10-Q, filed May 14, 2026.

Filed: May 14, 2026, 8:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001410098-26-000021

Line item	For the Three Months Ended March 31, 2026	For the Three Months Ended March 31, 2025
Revenue:
Product sales, net	$121,916	$39,082
Contract revenue	5,511	-
Total Revenue	127,427	39,082
Cost of sales (exclusive of amortization of intangibles)	12,005	1,545
Amortization of intangibles	10,300	52
Gross profit	105,122	37,485
Operating Expenses:

Item 1. Unaudited Condensed Consolidated Financial Statements.

FAQ

What is CorMedix's contract revenue — total revenue?: CorMedix (CRMD) reported contract revenue — total revenue of $5.51M in Q1 2026.
What does contract revenue — total revenue mean?: This metric represents the total revenue generated specifically from contractual arrangements, such as licensing agreements, research collaborations, or service-based partnerships. It reflects the company's ability to monetize its intellectual property or specialized capabilities through external business relationships rather than direct product sales. Monitoring this stream helps investors assess the diversification of income sources and the strategic value of the company's partnership ecosystem.